BRPI0507622A - composto baseado em ácido hialurÈnico, sal de sódio, processo para preparar um composto ou um seu sal, composição farmacêutica, produto medicinal e dispositivo médico para uso humano ou veterinário, e, uso de composto ou de seu sal - Google Patents
composto baseado em ácido hialurÈnico, sal de sódio, processo para preparar um composto ou um seu sal, composição farmacêutica, produto medicinal e dispositivo médico para uso humano ou veterinário, e, uso de composto ou de seu salInfo
- Publication number
- BRPI0507622A BRPI0507622A BRPI0507622-6A BRPI0507622A BRPI0507622A BR PI0507622 A BRPI0507622 A BR PI0507622A BR PI0507622 A BRPI0507622 A BR PI0507622A BR PI0507622 A BRPI0507622 A BR PI0507622A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- salt
- hyaluronic acid
- preparing
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000347A ITMI20040347A1 (it) | 2004-02-26 | 2004-02-26 | Nuovo farmaco di associazione |
PCT/IB2005/000506 WO2005085293A1 (en) | 2004-02-26 | 2005-02-25 | Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0507622A true BRPI0507622A (pt) | 2007-07-03 |
BRPI0507622B1 BRPI0507622B1 (pt) | 2018-07-17 |
BRPI0507622B8 BRPI0507622B8 (pt) | 2021-05-25 |
Family
ID=34917538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0507622A BRPI0507622B8 (pt) | 2004-02-26 | 2005-02-25 | composto baseado em ácido hialurônico, processo para preparar um composto ou um sal do mesmo, composição farmacêutica, produto medicinal e dispositivo médico para uso humano ou veterinário, e,uso de composto ou de um sal do mesmo |
Country Status (18)
Country | Link |
---|---|
US (1) | US7834173B2 (pt) |
EP (1) | EP1718679B1 (pt) |
JP (2) | JP4870068B2 (pt) |
CN (1) | CN100551932C (pt) |
AT (1) | ATE373681T1 (pt) |
BR (1) | BRPI0507622B8 (pt) |
CA (1) | CA2556942C (pt) |
DE (1) | DE602005002538T2 (pt) |
ES (1) | ES2293538T3 (pt) |
HK (1) | HK1099032A1 (pt) |
IL (1) | IL177072A (pt) |
IT (1) | ITMI20040347A1 (pt) |
PL (1) | PL1718679T3 (pt) |
PT (1) | PT1718679E (pt) |
RU (1) | RU2383554C2 (pt) |
SI (1) | SI1718679T1 (pt) |
UA (1) | UA91673C2 (pt) |
WO (1) | WO2005085293A1 (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE20060049A1 (en) * | 2006-01-25 | 2007-08-08 | Eurand Pharmaceuticals Ltd | A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents |
ITMI20062134A1 (it) * | 2006-11-08 | 2008-05-09 | Cbb Net S A | Preparaziobne di esteri della diacereina con acido ialuronico e loro formulazioni per l'impiego farmaceutico |
EP2097116B1 (en) * | 2006-12-22 | 2012-09-12 | Laboratoire Medidom S.A. | In situ system for intra-articular chondral and osseous tissue repair |
ITMI20072237A1 (it) * | 2007-11-27 | 2009-05-28 | Sigea Srl | Esteri misti butirrico-formico di polisaccaridi acidi, loro preparazione ed uso come dermocosmetici |
WO2009133430A1 (en) * | 2008-04-30 | 2009-11-05 | Wockhardt Research Centre | Topical compositions of rhein or diacerein |
US8722644B2 (en) | 2010-01-04 | 2014-05-13 | Holy Stone Healthcare Co., Ltd. | Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
US20140163217A1 (en) * | 2010-07-29 | 2014-06-12 | Universite De Geneve | Process for the esterification of hyaluronic acid with hydrophobic organic compounds |
CN102603575B (zh) * | 2012-01-04 | 2014-08-13 | 丛晓东 | 大精酸共晶物、其制备方法、纯化方法及其在制备治疗糖尿病并发症药物中的应用 |
GB2501943B (en) * | 2012-05-10 | 2020-09-23 | Zeiss Carl Meditec Ag | Ophthalmic viscoelastic device |
RU2534789C1 (ru) * | 2013-06-19 | 2014-12-10 | Сергей Алексеевич Успенский | Твердофазный способ получения водорастворимого биоактивного нанокомпозита на основе модифицированной лимонной кислотой гиалуроновой кислоты и наночастиц золота |
KR101486147B1 (ko) * | 2013-07-09 | 2015-01-23 | 주식회사 엘지생활건강 | Tslp 분비 저해능 및 이에 의한 알러지성 질환의 개선능을 가지는 조성물 |
MA41912A (fr) * | 2015-04-07 | 2018-02-13 | Hyalblue S R L | Esters de glycosaminoglycane, procédés pour leur préparation et leur utilisation dans des formulations à usage ophtalmique |
WO2020002597A1 (en) * | 2018-06-29 | 2020-01-02 | Merz Pharma Gmbh & Co. Kgaa | Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof |
CN109833292A (zh) * | 2019-02-23 | 2019-06-04 | 河南省人民医院 | 一种双醋瑞因滴眼液及其用途 |
CN112138169A (zh) * | 2020-09-14 | 2020-12-29 | 广东药科大学 | 天然多糖在增加难溶性药物溶解度中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4788187A (en) * | 1983-04-29 | 1988-11-29 | Rorer Pharmaceutical Corporation | Benzocyclobutene aminoalkylene ethers and thioethers, pharmaceutical composition and use |
NZ245989A (en) * | 1992-02-28 | 1995-02-24 | Lilly Industries Ltd | Anthraquinone derivatives and pharmaceutical compositions |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
EP0588255A1 (en) * | 1992-09-12 | 1994-03-23 | Dott Limited Company | Physiologically active peptide compositions |
CA2094203A1 (en) * | 1993-04-16 | 1994-10-17 | Derek A. Willoughby | Inhibition of angiogenesis |
US5612321A (en) * | 1995-06-22 | 1997-03-18 | Hercules Incorporated | Antioxidant grafted polysaccharides |
FR2751615B1 (fr) * | 1996-07-23 | 1998-09-18 | Otor Sa | Plateau et flan en matiere en feuille de carton |
JP3322203B2 (ja) * | 1997-01-31 | 2002-09-09 | 田辺製薬株式会社 | 医薬組成物 |
KR20010025040A (ko) * | 1998-05-20 | 2001-03-26 | 나가야마 오사무 | 관절질환 치료제 및 히알루론산의 결합체 |
ITMI20022745A1 (it) * | 2002-12-23 | 2004-06-24 | Coimex Scrl United Companies | Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione. |
-
2004
- 2004-02-26 IT IT000347A patent/ITMI20040347A1/it unknown
-
2005
- 2005-02-25 EP EP05708619A patent/EP1718679B1/en active Active
- 2005-02-25 JP JP2007500318A patent/JP4870068B2/ja active Active
- 2005-02-25 ES ES05708619T patent/ES2293538T3/es active Active
- 2005-02-25 CA CA2556942A patent/CA2556942C/en not_active Expired - Fee Related
- 2005-02-25 PT PT05708619T patent/PT1718679E/pt unknown
- 2005-02-25 AT AT05708619T patent/ATE373681T1/de active
- 2005-02-25 BR BRPI0507622A patent/BRPI0507622B8/pt not_active IP Right Cessation
- 2005-02-25 US US10/590,625 patent/US7834173B2/en not_active Expired - Fee Related
- 2005-02-25 DE DE602005002538T patent/DE602005002538T2/de active Active
- 2005-02-25 UA UAA200609263A patent/UA91673C2/ru unknown
- 2005-02-25 WO PCT/IB2005/000506 patent/WO2005085293A1/en active IP Right Grant
- 2005-02-25 RU RU2006134015/04A patent/RU2383554C2/ru active
- 2005-02-25 CN CNB2005800036341A patent/CN100551932C/zh not_active Expired - Fee Related
- 2005-02-25 SI SI200530094T patent/SI1718679T1/sl unknown
- 2005-02-25 PL PL05708619T patent/PL1718679T3/pl unknown
-
2006
- 2006-07-25 IL IL177072A patent/IL177072A/en active IP Right Grant
-
2007
- 2007-05-17 HK HK07105217.9A patent/HK1099032A1/xx not_active IP Right Cessation
-
2011
- 2011-07-21 JP JP2011160091A patent/JP2011252153A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP4870068B2 (ja) | 2012-02-08 |
PL1718679T3 (pl) | 2008-01-31 |
RU2006134015A (ru) | 2008-04-10 |
SI1718679T1 (sl) | 2008-02-29 |
EP1718679B1 (en) | 2007-09-19 |
PT1718679E (pt) | 2007-11-27 |
IL177072A (en) | 2011-02-28 |
ITMI20040347A1 (it) | 2004-05-26 |
ATE373681T1 (de) | 2007-10-15 |
US20070203094A1 (en) | 2007-08-30 |
EP1718679A1 (en) | 2006-11-08 |
CN100551932C (zh) | 2009-10-21 |
DE602005002538D1 (de) | 2007-10-31 |
JP2007524753A (ja) | 2007-08-30 |
CN1914228A (zh) | 2007-02-14 |
US7834173B2 (en) | 2010-11-16 |
BRPI0507622B1 (pt) | 2018-07-17 |
BRPI0507622B8 (pt) | 2021-05-25 |
DE602005002538T2 (de) | 2008-06-19 |
HK1099032A1 (en) | 2007-08-03 |
UA91673C2 (ru) | 2010-08-25 |
JP2011252153A (ja) | 2011-12-15 |
WO2005085293A1 (en) | 2005-09-15 |
RU2383554C2 (ru) | 2010-03-10 |
IL177072A0 (en) | 2006-12-10 |
CA2556942A1 (en) | 2005-09-15 |
CA2556942C (en) | 2012-05-29 |
ES2293538T3 (es) | 2008-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0507622A (pt) | composto baseado em ácido hialurÈnico, sal de sódio, processo para preparar um composto ou um seu sal, composição farmacêutica, produto medicinal e dispositivo médico para uso humano ou veterinário, e, uso de composto ou de seu sal | |
DE60316291D1 (de) | Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung | |
BR112012009376A2 (pt) | composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso | |
SMT201300095B (it) | Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia | |
NO20083780L (no) | Topisk sammensetning omfattende en antibakteriell substans | |
BR112013030894A2 (pt) | moduladores do sistema imune | |
BR112012027034A2 (pt) | inibidores da arginase e suas aplicações terapêuticas | |
BR112015014372A8 (pt) | inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas". | |
BRPI0516842A (pt) | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por lxr alfa e/ou lxr beta agonistas e uso desses compostos | |
BR112014018421A8 (pt) | Composições antimicrobianas compreendendo dgla, 15-ohepa e/ou 15-hetre e métodos de uso das mesmas | |
BR0307294A (pt) | ésteres de ácido fluorenocarboxìlico, processo para sua preparação bem como seu uso como medicamento | |
BRPI0924460A2 (pt) | composição farmacêutica para uso em oftalmologia médica e veterinária | |
BRPI0805826B8 (pt) | compostos espiro-substituídos, composição farmacêutica e uso | |
CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
BRPI0507351A (pt) | composto ou um seu sal farmaceuticamente aceitável ou éster hidrolisável in vivo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um seu sal farmaceuticamente aceitável ou éster hidrolisável in vivo, e, métodos para produzir um efeito inibidor do ciclo celular, anti-proliferação celular, em um animal de sangue quente, para tratar de uma doença, para tratar de cáncer em um animal de sangue quente e para produzir um efeito inibidor da cdk em um animal de sangue quente | |
BRPI0720500A8 (pt) | Preparação líquida transdérmica | |
CA2692191C (en) | Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases | |
NO20084478L (no) | Konjugerte lipidderivater | |
BRPI0915513B8 (pt) | compostos derivados de ácido fenóxi-cromano carboxílico 6-substituído, composições farmacêuticas compreendendo os referidos compostos, uso dos mesmos, e processo para a preparação destes | |
BRPI0520258A2 (pt) | uso de uma composição farmacêutica, método para preparar uma composição farmacêutica, e, uso de uma quantidade eficaz de acetato de eslicarbazepina | |
AR059864A1 (es) | Compuesto de benzamida composicion farmaceutica que lo comprende su uso para preparar un medicamento y procedimientos para su preparacion | |
EA201070625A1 (ru) | Система доставки лекарственного средства для введения водорастворимого катионного и амфифильного фармацевтически активного вещества | |
BR112015001627A2 (pt) | composição farmacêutica, respectivos usos e método para diminuir a frequência de micção | |
MX2009012713A (es) | Nuevos derivados de acido 3-fenil acrilico de receptores de tipo ppar, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas. | |
Torrecillas-Baena et al. | Comparative Study of the Efficacy of EHO-85, a Hydrogel Containing Olive Tree (Olea europaea) Leaf Extract, in Skin Wound Healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/02/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B15V | Prolongation of time limit allowed | ||
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 18A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2711 DE 20-12-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |